Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-05-003048
Filing Date
2005-03-15
Accepted
2005-03-15 17:15:56
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD END OF DECEMBER 31, 2004 a06814e10vk.htm 10-K 1006336
2 EXHIBIT 23.01 a06814exv23w01.txt EX-23.01 857
3 EXHIBIT 31.1 a06814exv31w1.txt EX-31.1 3957
4 EXHIBIT 31.2 a06814exv31w2.txt EX-31.2 3974
5 EXHIBIT 32 a06814exv32.txt EX-32 2646
6 GRAPHIC a06814a0681400.gif GRAPHIC 7289
7 GRAPHIC a06814a0681401.gif GRAPHIC 6967
  Complete submission text file 0000950137-05-003048.txt   1034177
Mailing Address
Business Address 2110 RUTHERFORD ROAD CARLSBAD CA 92008 7604944200
CANCERVAX CORP (Filer) CIK: 0001131907 (see all company filings)

EIN.: 522243564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50440 | Film No.: 05682549
SIC: 2836 Biological Products, (No Diagnostic Substances)